Table 6.
Experts’ Recommendations for the Selection of the Appropriate Inhalation Device in Chronic Obstructive Pulmonary Disease
| # | It is Strongly Recommended to … |
|---|---|
| 1 | Consider COPD pathophysiological aspects as well as patients’ clinical status and disease severity/evolution when selecting an inhalation device |
| 2 | Take into account the specific characteristics of each inhalation device |
| 3 | Assess patients’ ability to perform a correct inhalation maneuver and the specific requirements for each inhalation device |
| 4 | Evaluate patients’ inspiratory flow rate or inspiratory capacity before selecting an inhalation device |
| 5 | Take into account patients’ history of exacerbations or other events that may affect their ability to perform adequate inhalation |
| 6 | Regularly review patients’ inhalation maneuver and check whether the inhalation device meets their needs |
| 7 | Use an active inhalation device, such as pMDI or SMI, in patients with reduced inspiratory capacity |
| 8 | Consider using a valved holding chamber with SMI or pMDI devices in fragile patients with inspiratory and/or coordination difficulties |
| 9 | Use inhalation devices that generate a low oropharyngeal and high lung deposition |
| 10 | Check patients’ inhalation maneuver during every visit and, where necessary, resolve errors or even change the inhaler |
Abbreviations: COPD, chronic obstructive pulmonary disease; pMDI, pressurized metered-dose inhaler; SMI, soft mist inhaler.